Caffeine Therapy for Apnea of Prematurity | Zendy

Barbara Schmidt | Zendy; Robin S. Roberts | Zendy; Peter G. Davis | Zendy; Lex W. Doyle | Zendy; Keith J. Barrington | Zendy; Arne Ohlsson | Zendy; Alfonso Solimano | Zendy; Win Tin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Caffeine Therapy for Apnea of Prematurity

Author(s) -

Barbara Schmidt,

Robin S. Roberts,

Peter G. Davis,

Lex W. Doyle,

Keith J. Barrington,

Arne Ohlsson,

Alfonso Solimano,

Win Tin

Publication year - 2006

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa054065

Subject(s) - medicine , apnea of prematurity , caffeine , apnea , mechanical ventilation , anesthesia , ventilation (architecture) , low birth weight , pediatrics , intensive care medicine , pregnancy , gestational age , genetics , biology , mechanical engineering , engineering

Methylxanthines reduce the frequency of apnea of prematurity and the need for mechanical ventilation during the first seven days of therapy. It is uncertain whether methylxanthines have other short- and long-term benefits or risks in infants with very low birth weight.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research